Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound sophora decoction is a traditional multi-herb medicinal decoction studied as an anti-inflammatory treatment for ulcerative colitis. Based on the provided publication, it appears to act as a **complex botanical combination therapy** that modulates intestinal inflammation in part by inhibiting cyclic GMP-AMP synthase signaling and regulating macrophage polarization, thereby reducing colitis-associated immune activation. It is not identifiable from the provided evidence as a single molecular entity or a branded pharmaceutical product, but rather as a named traditional herbal formulation under preclinical or early investigational study for ulcerative colitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound sophora decoction.